ARS Investment Partners’s Regeneron Pharmaceuticals REGN Stock Holding History

ARS Investment Partners’s Portfolio REGN Stock Details REGN Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$16.2M	Buy
2025 Q2	$10.9M	Buy
2025 Q1	$4.61M	Sell
2024 Q4	$4.62M	Sell
2024 Q3	$12.6M	Buy
2024 Q2	$12.5M	Sell
2024 Q1	$11.6M	Buy
2022 Q4	–	Sell
2022 Q3	$551K	Buy